Home › Funds › Citadel Advisors › MRK

Citadel Advisors position in MRK

MERCK & CO INC · Health Care

Citadel Advisors reported holding 3,035,100 shares of MRK (MERCK & CO INC) in its Q3 2026 13F filing — a position valued at US$441.0M, representing 0.52% of its reported portfolio and ranking #35 among its reported holdings. Citadel Advisors has disclosed MRK holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)3.04M sh
Reported value held$441.03M
Portfolio Weight0.52%
First reportedQ3 2021
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Citadel Advisors's MRK position evolved

Citadel Advisors first disclosed a stake in MRK in Q3 2021 at 9,204,932 shares (US$691.4M). The position peaked in Q4 2022 at 10,359,668 shares, worth US$1.15B. Across 21 filings, Citadel Advisors increased the stake 10 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 3,035,100 shares valued at US$441.0M — an increase of 1,101,433 shares quarter over quarter.. Notable position changes include a 117% increase in Q2 2025 (shares rose 7% over the following quarter), a 78% trim in Q3 2025 (shares rose 26% over the following quarter), a 249% increase in Q4 2025 (shares rose 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 9.20M $691.38M New
Q4 2021 10.00M $766.28M Add
Q1 2022 8.96M $735.32M Reduce
Q2 2022 7.38M $672.71M Reduce
Q3 2022 9.32M $802.42M Add
Q4 2022 10.36M $1.15B Add
Q1 2023 5.69M $605.77M Reduce
Q2 2023 5.72M $659.79M Hold
Q3 2023 1.60M $164.35M Reduce
Q4 2023 1.34M $146.04M Reduce
Q1 2024 1.73M $228.14M Add
Q2 2024 1.25M $154.28M Reduce
Q3 2024 1.38M $156.54M Add
Q4 2024 1.38M $137.13M Hold
Q1 2025 2.05M $183.89M Add
Q2 2025 4.45M $351.94M Add
Q3 2025 968.05K $81.25M Reduce
Q4 2025 3.38M $355.56M Add
Q1 2026 3.74M $450.27M Add
Q2 2026 1.93M $248.48M Reduce
Q3 2026 3.04M $441.03M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO INC) is a Health Care company. 31 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$33.14B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has Citadel Advisors held MRK?

Citadel Advisors has disclosed MRK holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is Citadel Advisors's current position in MRK?

As of Q3 2026, Citadel Advisors holds 3.04M shares of MRK (MERCK & CO INC), valued at $441.03M, representing 0.52% of its reported portfolio and ranking #35.

Has Citadel Advisors been buying or selling MRK?

In the latest 13F filing (Q3 2026), Citadel Advisors increased its position in MRK. The position peaked in Q4 2022 at 10.36M shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.